Detalhe da pesquisa
1.
Creating work environments where people of all genders in gynecologic oncology can thrive: An SGO evidence-based review.
Gynecol Oncol
; 164(3): 473-480, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35000796
2.
Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer.
Ann Oncol
; 30(4): 551-557, 2019 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30753272
3.
The new classifications of ovarian, fallopian tube, and primary peritoneal cancer and their clinical implications.
Ann Oncol
; 28(suppl_8): viii8-viii12, 2017 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29232468
4.
PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies.
Ann Oncol
; 25(1): 32-40, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24225019
5.
Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions.
Br J Cancer
; 109(4): 1072-8, 2013 Aug 20.
Artigo
Inglês
| MEDLINE | ID: mdl-23867999
6.
Clinical implications of using molecular diagnostics for ovarian cancers.
Ann Oncol
; 24 Suppl 10: x22-26, 2013 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-24265398
7.
Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity.
Br J Cancer
; 102(3): 495-9, 2010 Feb 02.
Artigo
Inglês
| MEDLINE | ID: mdl-20051952
8.
Proteomics as a guiding tool for more effective personalized therapy.
Ann Oncol
; 21 Suppl 7: vii205-10, 2010 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-20943616
9.
Ovarian cancer in the proteomics era.
Int J Gynecol Cancer
; 18 Suppl 1: 1-6, 2008.
Artigo
Inglês
| MEDLINE | ID: mdl-18336391
10.
L651582: a novel antiproliferative and antimetastasis agent.
J Natl Cancer Inst
; 82(1): 54-60, 1990 Jan 03.
Artigo
Inglês
| MEDLINE | ID: mdl-2152805
11.
Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancer.
J Natl Cancer Inst
; 86(1): 18-24, 1994 Jan 05.
Artigo
Inglês
| MEDLINE | ID: mdl-7505830
12.
Molecular insights into cancer invasion: strategies for prevention and intervention.
Cancer Res
; 55(9): 1856-62, 1995 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-7728753
13.
In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates.
Cancer Res
; 52(11): 3208-12, 1992 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-1591730
14.
Suramin inhibits laminin- and thrombospondin-mediated melanoma cell adhesion and migration and binding of these adhesive proteins to sulfatide.
Cancer Res
; 50(18): 5937-42, 1990 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-2393863
15.
An improved method for construction of directionally cloned cDNA libraries from microdissected cells.
Cancer Res
; 58(23): 5326-8, 1998 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-9850058
16.
Structure-function analysis of signal and growth inhibition by carboxyamido-triazole, CAI.
Cancer Res
; 54(4): 935-42, 1994 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-8313384
17.
Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers.
Cancer Res
; 56(3): 569-73, 1996 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-8564973
18.
Phase I trial of micronized formulation carboxyamidotriazole in patients with refractory solid tumors: pharmacokinetics, clinical outcome, and comparison of formulations.
J Clin Oncol
; 15(5): 1985-93, 1997 May.
Artigo
Inglês
| MEDLINE | ID: mdl-9164210
19.
Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndrome.
J Clin Oncol
; 8(1): 155-60, 1990 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-2295906
20.
Invasion and metastasis: biology and clinical potential.
Pharmacol Ther
; 52(2): 235-44, 1991 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-1818338